# Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

> **NCT05699005** · PHASE1 · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 236 (estimated)

## Conditions studied

- Cardiogenic Shock
- Extracorporeal Membrane Oxygenation
- Transfusion Related Complication
- Anemia
- Oxygen Delivery

## Interventions

- **DRUG:** Packed Red Blood Cells (PRBCs)

## Key facts

- **NCT ID:** NCT05699005
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-18
- **Primary completion:** 2026-09-18
- **Final completion:** 2026-12-18
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05699005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05699005, "Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT05699005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*